OmiCure
OmiCure provides a personalized cancer treatment selection service utilizing AI to analyze a patient's tumor genomics and transcriptomics. By comparing this data against an extensive knowledge base of therapies and nutriments, OmiCure identifies the most suitable treatment or dietary options. Their OmiCure® test analyzes genomic sequencing data, including RNA sequencing and whole-exome sequencing, to identify gene expression changes or genomic alterations. The AI then generates a report for physicians, detailing potential therapies and diet options based on thousands of cancer drug-gene and nutriment-gene interactions. This service aims to assist patients and physicians in making informed treatment decisions by providing actionable, personalized knowledge, especially for patients with resistant cancers, those who have failed standard treatments, or have rare tumors.
OmiCure
OmiCure provides a personalized cancer treatment selection service utilizing AI to analyze a patient's tumor genomics and transcriptomics. By comparing this data against an extensive knowledge base of therapies and nutriments, OmiCure identifies the most suitable treatment or dietary options. Their OmiCure® test analyzes genomic sequencing data, including RNA sequencing and whole-exome sequencing, to identify gene expression changes or genomic alterations. The AI then generates a report for physicians, detailing potential therapies and diet options based on thousands of cancer drug-gene and nutriment-gene interactions. This service aims to assist patients and physicians in making informed treatment decisions by providing actionable, personalized knowledge, especially for patients with resistant cancers, those who have failed standard treatments, or have rare tumors.